1. Hennequin C, Giocanti N, Favaudon V: Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.Cancer Res 56: 1842–1850, 1996.
2. Matsuura M, Hasegawa M, Hayakawa K, Kawashima M, Nasu S, Nakamura Y, Hayakawa K, Mitsuhashi N, Niibe H: Experimental study of the effects on apoptosis of docetaxel alone and in combination with irradiation.Oncol Rep 7: 289–293, 2000.
3. Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L: Docetaxel enhances tumor radioresponsein vivo.Clin Cancer Res 3: 2431–2438, 1997.
4. Mason KA, Kishi K, Hunter N, Buchmiller L, Akimoto T, Komaki R, Milas L: Effect of docetaxel on the therapeutic ratio of fractionated radiotherapyin vivo.Clin Cancer Res 5: 4191–4198, 1999.
5. Valero V, Holmes FA, Walters RS, Theriault RL, Esparza L, Fraschini G, Fonseca GA, Bellet RE, Buzdar AU, Hortobagyi GN: Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.J Clin Oncol 13: 2886–2894, 1995.